A citation-based method for searching scientific literature

Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles, Susan L Neuhausen, Mary B Daly, Ellen Matloff, Joanne L Blum, Paul Sabbatini, Richard R Barakat, Clifford Hudis, Larry Norton, Kenneth Offit, Timothy R Rebbeck. J Clin Oncol 2008
Times Cited: 348



Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski, Tomasz Huzarski, Andrea Eisen, William D Foulkes, Charmaine Kim-Sing, Peter Ainsworth, Nadine Tung, Henry T Lynch, Susan Neuhausen, Kelly A Metcalfe, Islay Thompson, Joan Murphy, Ping Sun, Steven A Narod. J Clin Oncol 2014
Times Cited: 328




List of shared articles



Times cited

Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1/2 pathogenic variant carriers among a cohort study in a single institution.
Yusuke Kobayashi, Akira Hirasawa, Tatsuyuki Chiyoda, Arisa Ueki, Kenta Masuda, Kumiko Misu, Miho Kawaida, Shigenori Hayashi, Fumio Kataoka, Kouji Banno,[...]. Jpn J Clin Oncol 2021
0


Value of adjuvant chemotherapy and informed microscopic examination for occult gynecologic cancer detected upon risk-reducing salpingo-oophorectomy after chemotherapy for BRCA1/2-associated breast cancer: a case report.
Shiho Kuji, Haruhiro Kondo, Tatsuru Ohara, Imari Deura, Akiko Tozawa-Ono, Ohsuke Migita, Hisanori Kawamoto, Koichiro Tsugawa, Motohiro Chosokabe, Junki Koike,[...]. Jpn J Clin Oncol 2021
0

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
21

0

Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriers.
Renee Cowan, Silvana Pedra Nobre, Nisha Pradhan, Maya Yasukawa, Qin C Zhou, Alexia Iasonos, Robert A Soslow, Angela G Arnold, Magan Trottier, Amanda Catchings,[...]. Gynecol Oncol 2021
0


Sexual function, menopausal symptoms, depression and cancer worry in women with BRCA mutations.
C Bethan Powell, Amy Alabaster, Amy Le, Nicole Stoller, Mary Anne Armstrong, Tina Raine-Bennett. Psychooncology 2020
2


Population Screening for Inherited Predisposition to Breast and Ovarian Cancer.
Ranjit Manchanda, Sari Lieberman, Faiza Gaba, Amnon Lahad, Ephrat Levy-Lahad. Annu Rev Genomics Hum Genet 2020
10

Risk factors for sexual dysfunction in BRCA mutation carriers after risk-reducing salpingo-oophorectomy.
Jessica L Chan, Suneeta Senapati, Lauren N C Johnson, Laura DiGiovanni, Chan Voong, Samantha F Butts, Susan M Domchek. Menopause 2019
11

Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review.
Ye-Lei Xiao, Kang Wang, Qiang Liu, Jie Li, Xiang Zhang, Hong-Yuan Li. Clin Breast Cancer 2019
11

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy.
Janusz Menkiszak, Anita Chudecka-Głaz, Aneta Cymbaluk-Płoska, Aleksander Celewicz, Zbigniew Kojs, Mariusz Szajda, Maria Świniarska, Ryszard Bedner, Anna Jurczak, Marta Celewicz,[...]. Hered Cancer Clin Pract 2019
0

Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-Oophorectomy.
Annelise M Wilhite, Makinna C Oestreich, Megan Olson, Sabrina M Bedell, Danielle Westenberg, Ananta Bangdiwala, Salman Ikramuddin, Monica Sanchez-Avila, Robert D Madoff, Mahmoud A Khalifa,[...]. Obstet Gynecol 2019
3

Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199).
Phuong L Mai, Austin Miller, Mitchell H Gail, Steven Skates, Karen Lu, Mark E Sherman, Olga B Ioffe, Gustavo Rodriguez, David E Cohn, John Boggess,[...]. JNCI Cancer Spectr 2019
6

Preventing Breast Cancer in High-Risk Women: Is There Still a Role for Oophorectomy?
Barbara M Norquist, Elizabeth M Swisher, Rachel L Yung. JNCI Cancer Spectr 2019
0

Cancer Risk-Reducing Opportunities in Gynecologic Surgery.
Carolyn Piszczek, Jun Ma, Claire H Gould, Paul Tseng. J Minim Invasive Gynecol 2018
2

Management of hereditary breast and ovarian cancer.
Hideko Yamauchi, Junko Takei. Int J Clin Oncol 2018
11


Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.
Denise R Nebgen, Jean Hurteau, Laura L Holman, Andrea Bradford, Mark F Munsell, Beth R Soletsky, Charlotte C Sun, Gary B Chisholm, Karen H Lu. Gynecol Oncol 2018
27


Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
Thomas B Silverman, Alejandro Vanegas, Awilda Marte, Jennie Mata, Margaret Sin, Juan Carlos Rodriguez Ramirez, Wei-Yann Tsai, Katherine D Crew, Rita Kukafka. BMC Health Serv Res 2018
6

Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo. Cochrane Database Syst Rev 2018
27

Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations.
C Bethan Powell, Amy Alabaster, Mary Anne Armstrong, Nicole Stoller, Tina Raine-Bennett. Gynecol Oncol 2018
7

Cell Origins of High-Grade Serous Ovarian Cancer.
Jaeyeon Kim, Eun Young Park, Olga Kim, Jeanne M Schilder, Donna M Coffey, Chi-Heum Cho, Robert C Bast. Cancers (Basel) 2018
69

An Applied Framework in Support of Shared Decision Making about BRCA Genetic Testing.
Thomas B Silverman, Gilad J Kuperman, Alejandro Vanegas, Margaret Sin, Jill Dimond, Katherine D Crew, Rita Kukafka. AMIA Annu Symp Proc 2018
3

Can we prevent BRCA1-associated breast cancer by RANKL inhibition?
Joanne Kotsopoulos, Christian Singer, Steven A Narod. Breast Cancer Res Treat 2017
14

Role of Fallopian Tubes in the Development of Ovarian Cancer.
Camila Corzo, Maria D Iniesta, Maria Guadalupe Patrono, Karen H Lu, Pedro T Ramirez. J Minim Invasive Gynecol 2017
19

Genetics of gynaecological cancers.
Panayiotis Constantinou, Marc Tischkowitz. Best Pract Res Clin Obstet Gynaecol 2017
9

Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer.
Y C Lee, M Bressel, P Grant, P Russell, C Smith, S Picken, S Camm, B E Kiely, R L Milne, S A McLachlan,[...]. Fam Cancer 2017
1


Risk-reducing salpingectomy: Let us be opportunistic.
Kara C Long Roche, Nadeem R Abu-Rustum, Mlica Nourmoussavi, Oliver Zivanovic. Cancer 2017
18